Alzheimer's Disease Pathologic Cascades: Who Comes First, What Drives What

被引:60
作者
Swerdlow, Russell H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Kansas, Sch Med, Landon Ctr Aging, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA
[3] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
[4] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA
关键词
Aging; Alzheimer's disease; Amyloid; Brain; Oxidative stress; Mitochondria; AMYLOID PRECURSOR PROTEIN; PROGRESSIVE SUPRANUCLEAR PALSY; FAMILIAL BRITISH DEMENTIA; NEURONAL CELL-DEATH; OXIDATIVE STRESS; DNA-REPLICATION; NEUROFIBRILLARY PATHOLOGY; MITOCHONDRIAL DYSFUNCTION; A-BETA; 8-OXODEOXYGUANOSINE TRIPHOSPHATE;
D O I
10.1007/s12640-011-9272-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review discusses known and speculated relationships between Alzheimer's disease (AD) biochemical, molecular, and histologic phenomena. In the AD brain, various pathologies including neuritic plaques, neurofibrillary tangles, synaptic loss, oxidative stress, cell cycle re-entry, and mitochondrial changes have all been described. In an attempt to explain what exactly goes wrong in the AD brain various investigators have proposed different heuristic and hierarchical schemes. It is important to accurately define the AD pathology hierarchy because treatments targeting the true apex of its pathologic cascade arguably have the best chance of preventing, mitigating, or even curing this disease.
引用
收藏
页码:182 / 194
页数:13
相关论文
共 139 条